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143Endovascular treatment for type Ia major endoleak
after endovascular aneurysm repair
Yoshiaki Katada, MD,a Shunichi Kondo, MD,b Taichi Kondo, MD,c and Tsuyoshi Yamabe, MD,b
Saitama, Fukushima, and Kanagawa, JapanWe report an 85-year-old woman who underwent an endovascular aneurysm
repair (EVAR) of an abdominal aortic aneurysm using a Zenith stent graft
(Cook Inc, Bloomington, Ind) with a coil embolization of an inferior mesenteric
artery. The EVAR was completed without any evidence of endoleak (A).
The patient subsequently developed a type Ia endoleak, detected by follow-
up computed tomography. For this endoleak, additional EVAR (aortic extender
cuff and large Palmaz stent [Cordis, Miami Lakes, Fla] placement) was per-
formed; however, the endoleak did not disappear completely. Thereafter, further
expansion of the endoleak sac was observed on follow-up computed tomography
(Cover), and additional therapy had to be considered.
The endovascular procedure was undertaken under local anesthesia. A 4F
catheter was placed into the endoleak channel that existed at the top of the stent
graft, and a 2.5F microcatheter was advanced and placed in the endoleak sac.
Coils and N-butyl 2-cyanoacrylate (NBCA)-lipiodol embolization was per-
formed (B), then the Zenith TX2 extension cuff (Cook Inc) was deployed just
after the left renal artery. At the ﬁnal angiography, the type Ia endoleak had
completely disappeared (C). At 6 months after the treatment, the endoleak
had completely disappeared, and there was no evidence of migration of the
NBCA-lipiodol cast with the coils.DISCUSSION
Type I endoleak can cause postoperative aneurysm rupture, with a mortality
rate of w50%.1 The treatment strategy for type Ia endoleak, including balloon
inﬂation, cuff placement, and large Palmaz stent placement, does not always
yield success. Surgical treatment is necessary for most of these patients. A few
reports of alternative endovascular therapy for type Ia endoleak have been pub-
lished, involving the use of coils, NBCA-lipiodol, the chimney technique, and
fenestrated/branched EVAR, and good results have been obtained.2,3
Type Ia endoleak is a high-pressure type of endoleak; therefore, we used the
combination of the NBCA-lipiodol and coil embolization, along with the Zenith
TX2 cuff, deployment to completely close the endoleak channel. This combina-
tion treatment concept appears to be an effective and safe method for the treat-
ment of type Ia endoleak after EVAR and has very great signiﬁcance in the
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